Trial intelligence / Profile preview

Qingxin Zishen Decoction for Menopausal Syndrome

NCT06132620Completed

Start
Apr 2017
Primary completion
Jun 2018
Modality
TCM (Traditional Chinese Medicine)
Countries
1
01

Overview

Randomised, open-label trial of Qingxin Zishen decoction in menopause (2 arms). Primary endpoints: Modified Kupperman Menopausal Index at 12 weeks, Hot flashes and sweats frequency/severity at 12 weeks and 2 more. Started Apr 2017; status: completed.

02

Drugs

Qingxin Zishen decoction
03

Conditions

menopause

Beyond the preview

Go deeper on NCT06132620.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06132620.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call